JPRN-C000000123已完成3 期
Randomized phase III study of 5-FU continuous infusion (5FUci) versus MTX+5-FU sequential therapy (MF) in gastric cancer with peritoneal metastasis (JCOG0106-MF, MF/5FU) - Randomized phase III study of 5-FU versus MTX+5-FU in gastric cancer with peritoneal metastasis (JCOG0106-MF, MF/5FU)
Japan Clinical Oncology Group(JCOG)0 个研究点目标入组 236 人开始时间: 2005年9月7日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 236
研究概览
简要总结
See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Massive pleural effusion (2) brain metastasis with symptoms (3) severe diarrhea (4) other severe medical conditions (infection, diabetes, hypertension, acute myocardial infarction, unstable angina, liver cirrhosis, intestinal pneumonia, pulmonary fibrosis) (5) other active malignancies
研究者
相似试验
已完成
3 期
Randomized phase III study of 5-FU continuous infusion (5-FUci) versus CPT-11 plus CDDP (CP) versus S-1 alone (S-1) in advanced gastric cancer (JCOG9912)advanced or recurrent gastric cancerJPRN-C000000062Japan Clinical Oncology Group(JCOG)690
已完成
2 期
Randomized phase II study of best available 5-FU versus low-dose Paclitaxiel in gastric cancer with peritoneal metastasis refractory to 5-FU containing regimen(JCOG0407)gastric neoplasmJPRN-C000000138Japan Clinical Oncology Group(JCOG)100
已完成
3 期
A Phase III Randomized, Multicenter Study Comparing Irinotevan and Cisplatin (IP) with Amrubicin and Cisplatin (AP) for the Treatment of Extensive-Stage Small-Cell Lung Cancer: (JCOG0509)extensive-disease small cell lung cancerJPRN-UMIN000000720Japan Clinical Oncology Group(JCOG)282
已完成
3 期
Randomized phase III trial comparing adjuvant oral UFT/LV to 5-FU/l-LV in stage III colorectal cancer (JCOG-0205-MF)Stage III colorectal cancerJPRN-C000000193Japan Clinical Oncology Group(JCOG)1,100
已完成
3 期
Phase III trial of neoadjuvant chemotherapy followed by surgery versus surgery alone for bulky stage I/II cervical cancer: Japan Clinical Oncology Group trial (JCOG0102)Patients with cervical cancerJPRN-C000000194Japan Clinical Oncology Group(JCOG)200